Ultrase MT12 (Amylase/Lipase/Protease Enteric Coated Capsules) Manufactured by: Axcan Scandipharm Inc NO prescription required |
| Name | Strength | Quantity | Price | ||||
| Brand | 39mg/12mg/39mg | 100 Gelcaps | $74.99 | Buy |
All prices in USD
ULTRASE and ULTRASE MT (pancrelipase) Capsules are orally administered capsules containing enteric-coated microspheres or minitablets of porcine pancreatic enzyme concentrate, predominantly pancreatic lipase, amylase, and protease.
Each ULTRASE Capsule contains:
Lipase
4,500 U.S.P. Units
Amylase
20,000 U.S.P. Units
Protease
25,000 U.S.P. Units
Each ULTRASE MT12 Capsule contains:
Lipase
12,000 U.S.P. Units
Amylase
39,000 U.S.P. Units
Protease
39,000 U.S.P. Units
Each ULTRASE MT18 Capsule contains:
Lipase
18,000 U.S.P. Units
Amylase
58,500 U.S.P. Units
Protease
58,500 U.S.P. Units
Each ULTRASE MT20 Capsule contains:
Lipase
20,000 U.S.P. Units
Amylase
65,000 U.S.P. Units
Protease
65,000 U.S.P. Units
ULTRASE and ULTRASE MT (pancrelipase) Capsules are designed to prevent inactivation by gastric acid thereby resulting in the delivery of high levels of biologically active enzymes into the duodenum. The enzymes catalyze the hydrolysis of fats into glycerol and fatty acids, starch into dextrins and sugars, and protein into proteoses and derived substances.
ULTRASE and ULTRASE MT (pancrelipase) Capsules are indicated for patients with partial or complete exocrine pancreatic insufficiency caused by: cystic fibrosis, chronic pancreatitis, pancreatectomy, and Shwachman's Syndrome. Pancrelipase capsules are also effective in controlling steatorrhea.
This medicine is a pancreatic enzyme combination used to improve food digestion in patients who do not produce enough enzymes on their own as a result of disease, surgery, or other conditions. It may also be used to treat other conditions as determined by your doctor.
